Sarcopenic obesity increases mortality rates in older adults, suggesting a need for better screening in primary care.
Sarcopenic obesity (SO) is a clinical condition characterized by the coexistence of reduced muscle mass and function along with obesity. The prevalence of SO increases with age, posing a threat to individuals’ physical independence. SO is particularly associated with a loss of physical abilities, a higher risk of falls, decreased quality of life, and increased mortality rates in older adults. Additionally, metabolic disorders related to obesity exacerbate the clinical severity of this condition. Among the screening tools used for SO, SARC-F + BMI (Strength, Ambulation, Rising from a Chair, Stair Climbing and History of Falling + Body Mass Index) and SARC-CaLF + PBF (SARC-F Combined with Calf Circumference + Percentage of Body Fat) stand out. However, both methods have limitations. Furthermore, screening with SARC-CaLF + PBF may require devices that are not suitable for use in primary care. This complicates the screening, early treatment, and determination of SO prevalence in the community. Therefore, it is necessary to develop sensitive screening tools suitable for use in primary care.
No takes yet. Share an insight, caveat, or question.
Özkaya et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: